Opexa Therapeutics Inc (NASDAQ:OPXA)

Data as of Jan 23
 +0.0111 / +1.36%
Today’s Change
Today|||52-Week Range

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Quarter 4
Quarter 1
Quarter 2
Quarter 3
Operating ActivitiesNet Income / Starting Line-3.8M-3.7M-4.2M-3.9M
Total Other Cash Flow99.1K431.2K313.9K297.2K
Funds From Operations-3.6M-3.1M-3.8M-3.5M
Funds From/For Other Operating Expenses66.7K780.4K-357.2K-280.0K
Net Cash Flow - Operating Activities-3.6M-3.9M-3.4M-3.2M
InvestingCapital Expenditures-45.0K-75.9K-51.3K-22.0K
Net Cash Flow Investing-45.0K-75.9K-51.4K-22.0K
FinancingShort Term Borrowings0.
Long Term Borrowings0.
Long Term Debt Reduction0.
Net Proceeds Stock Sale7.2M0.000.00648.2K
Common Preferred Redeemed0.
Common Dividends----------
Cash Dividends Paid - Total0.
Other Sources - Financing0.
Other Uses - Financing0.
Net Cash Flow - Financing7.2M0.000.00648.2K
Exchange RateEffect of Exchange Rate on Cash0.
Net Change In Cash3.5M-4.0M-3.4M-2.6M

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.